Chapters authored
New Diagnosis and Treatment Approaches to Post-Traumatic Stress Disorder
Post-traumatic stress disorder (PTSD) is a mental health condition and disorder causing psychological deterioration triggered by terrifying events or traumatic experiences either by experiencing or by witnessing it. Though many people have common feelings, PTSD symptoms vary from one person to another. So it is strongly recommended to focus on new diagnostic and therapeutic methods relying and structured on a neurobiological dimension by collecting and processing neuroimaging data. It is crucial to make a profound analysis of PTSD in terms of its ontological, biological, developmental, psychological, and sociological aspects. Both with the new treatment opportunities and involvement of in silico-based artificial intelligence applications, new psychotherapy techniques and new discourses in digital media will be possible. Within the scope of the study, ontological discussions are followed and juxtaposed by Neuro-Biological Perspectives on Genomics and Epigenomics as well as the clinical and neuro-imaginative perspectives and clinical overviews of PTSD. Besides, the neuro-developmental views in the context of children along with adverse childhood experiences (ACE) and their relation to PTSD are analyzed by emphasizing the significance of brain development. Sociological aspects of PTSD in the digital habitus are collocated to develop unique therapy approaches that embrace sociological perspectives of Information Society.
Part of the book: Stress-Related Disorders
Neurobiological Perspective and Personalized Treatment in Schizophrenia
Personalized treatment is the focus of researchers and comes into prominence for both genetic sciences and neurotechnology. Recently, clinical practice tries to follow the idea and principles of personalized medicine. Besides predicting an individual’s sensibility or predisposition for developing schizophrenia, pharmacogenetic and pharmacogenomic approaches attempt to define and acknowledge important indicators of clinical response to antipsychotics namely their efficacy and adverse effects. Particularly in the treatment of schizophrenia, clinicians are very helpless in resistant cases, and clinical pharmacogenomics contributes in a revolutionary way. With both phenotyping, namely Therapeutic Drug Monitoring (TDM) and genotyping, “big expectations” emerged both with the right drug, the right dose, and the right time. Both pharmacokinetic genotyping, CYP400 enzyme activity, and pharmacodynamic genotyping could be measured. The chapter handles schizophrenia with neurobiological views and covers personalized treatment approaches from various perspectives. Personalized treatment in the diagnosis and treatment of schizophrenia is presented first. Following comorbid schizophrenia in addition to the use of various substances, psychopharmacology of schizophrenia and the mechanism of action of antipsychotic drugs are presented. Genetics and epigenetics in schizophrenia are studied in detail and in silico application and computational approaches covering the feature extraction process and destructive impact of the metaverse are shared lastly.
Part of the book: Schizophrenia